Researchers outline individual peripheral arterial disease burden as well as the most at-risk patient populations and treatment recommendations.
News|Expert Interviews|August 14, 2020
CV Risk Stratification Decision Factors
A discussion on which factors to consider when assessing the need for management/reduction of cardiovascular risk.
Advertisement
Advertisement
Related to this article
Study findings tie continuous glucose monitoring measures to elevated cardiovascular risk in adults without diabetes.
An American Heart Association scientific statement shows earlier risk factors and social barriers driving cardiovascular disparities in Hispanic adults.
Data found reduced cardiovascular risk with hormone therapy, particularly among Black women and those starting treatment within 10 years of menopause.
The update adds efficacy and safety data on adults newly diagnosed with pulmonary arterial hypertension.
Advertisement
Advertisement
Trending on Drug Topics
1
Normal vs. Concerning COVID-19 Vaccine Reactions: A Pharmacist's Guide
2
What Is HIV PrEP and Who Needs It Most?
3
Pharmacists Are Vital in Complex, Team-Based Treatment of PAD
4
RSV Vaccine Coadministration Lowered Antibodies Despite Efficacy
5